EPHA2 and gastric cancer: We treated the sh-NC (i.e. negative control shRNA) and sh-EphA2 cells with ALW or DMSO (as negative control) and evaluated whether the inhibitory effect of ALW on gastric cancer cells was dependent on the EphA2 level.